$OPRX Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.04 down -150.00% YoY
• Reported revenue of $20.5M down -29.77% YoY
• OptimizeRx Corp is reiterating its fiscal year 2026 guidance, expecting revenue of $95 million to $100 million and adjusted EBITDA of $21 million to $25 million for the full year.